Intelligent Bio Solutions (NASDAQ:INBS) Trading 4.5% Higher

Intelligent Bio Solutions Inc. (NASDAQ:INBS) shot up 4.5% during trading on Thursday . The company traded as high as $3.28 and last traded at $2.80. 162,360 shares were traded during mid-day trading, a decline of 94% from the average session volume of 2,738,967 shares. The stock had previously closed at $2.68.

Intelligent Bio Solutions Trading Down 2.1 %

The stock’s fifty day moving average price is $4.24 and its 200 day moving average price is $3.95. The company has a quick ratio of 0.39, a current ratio of 0.57 and a debt-to-equity ratio of 0.07.

Intelligent Bio Solutions (NASDAQ:INBS) last released its quarterly earnings data on Friday, February 9th. The company reported ($2.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($3.24) by $1.17. Intelligent Bio Solutions had a negative net margin of 544.63% and a negative return on equity of 266.16%. The company had revenue of $0.76 million during the quarter. As a group, equities research analysts anticipate that Intelligent Bio Solutions Inc. will post -3.67 earnings per share for the current year.

Institutional Trading of Intelligent Bio Solutions

A hedge fund recently bought a new stake in Intelligent Bio Solutions stock. Sabby Management LLC acquired a new position in Intelligent Bio Solutions Inc. (NASDAQ:INBS) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 126,650 shares of the company’s stock, valued at approximately $367,000. Intelligent Bio Solutions accounts for about 0.3% of Sabby Management LLC’s portfolio, making the stock its 26th biggest holding. Sabby Management LLC owned approximately 8.52% of Intelligent Bio Solutions as of its most recent SEC filing. 32.97% of the stock is owned by institutional investors.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.